-
1
-
-
84867757134
-
Multidrug resistance in breast cancer: From in vitro models to clinical studies
-
PMID:22332018
-
Wind NS, Holen I. Multidrug resistance in breast cancer: from in vitro models to clinical studies. Int J Breast Cancer 2011; 2011:967419; PMID:22332018; http://dx.doi.org/10.4061/2011/967419
-
(2011)
Int J Breast Cancer
, vol.2011
, pp. 967419
-
-
Wind, N.S.1
Holen, I.2
-
2
-
-
33645123146
-
Drug transporters in pharmacokinetics
-
PMID:16532306
-
Petzinger E, Geyer J. Drug transporters in pharmacokinetics. Naunyn Schmiedebergs Arch Pharmacol 2006; 372:465-75; PMID:16532306; http://dx.doi.org/10.1007/s00210-006-0042-9
-
(2006)
Naunyn Schmiedebergs Arch Pharmacol
, vol.372
, pp. 465-475
-
-
Petzinger, E.1
Geyer, J.2
-
3
-
-
65349136896
-
Classical resistance mechanisms
-
PMID:19203536
-
Jäeger W. Classical resistance mechanisms. Int J Clin Pharmacol Ther 2009; 47:46-8; PMID:19203536; http://dx.doi.org/10.5414/CPP47046
-
(2009)
Int J Clin Pharmacol Ther
, vol.47
, pp. 46-48
-
-
Jäeger, W.1
-
4
-
-
40949121607
-
ABC multidrug transporters: Structure, function and role in chemoresistance
-
DOI 10.2217/14622416.9.1.105
-
Sharom FJ. ABC multidrug transporters: structure, function and role in chemoresistance. Pharmacogenomics 2008; 9:105-27; PMID:18154452; http://dx.doi.org/10.2217/14622416.9.1.105 (Pubitemid 351560534)
-
(2008)
Pharmacogenomics
, vol.9
, Issue.1
, pp. 105-127
-
-
Sharom, F.J.1
-
5
-
-
0034947674
-
From MDR to MXR: New understanding of multidrug resistance systems, their properties and clinical significance
-
Litman T, Druley TE, Stein WD, Bates SE. From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance. Cell Mol Life Sci 2001; 58:931-59; PMID:11497241; http://dx.doi.org/10.1007/PL00000912 (Pubitemid 32652819)
-
(2001)
Cellular and Molecular Life Sciences
, vol.58
, Issue.7
, pp. 931-959
-
-
Litman, T.1
Druley, T.E.2
Stein, W.D.3
Bates, S.E.4
-
6
-
-
78650055834
-
Prediction of venous thromboembolism in cancer patients
-
PMID:20829374
-
Ay C, Dunkler D, Marosi C, Chiriac AL, Vormittag R, Simanek R, Quehenberger P, Zielinski C, Pabinger I. Prediction of venous thromboembolism in cancer patients. Blood 2010; 116:5377-82; PMID:20829374; http://dx.doi.org/10. 1182/blood-2010-02-270116
-
(2010)
Blood
, vol.116
, pp. 5377-5382
-
-
Ay, C.1
Dunkler, D.2
Marosi, C.3
Chiriac, A.L.4
Vormittag, R.5
Simanek, R.6
Quehenberger, P.7
Zielinski, C.8
Pabinger, I.9
-
7
-
-
79955000458
-
Thrombosis in cancer: An update on prevention, treatment, and survival benefits of anticoagulants
-
PMID:21239784
-
Lee AY. Thrombosis in cancer: an update on prevention, treatment, and survival benefits of anticoagulants. Hematology Am Soc Hematol Educ Program 2010; 2010:144-9; PMID:21239784; http://dx.doi.org/10.1182/asheducation-2010.1. 144
-
(2010)
Hematology Am Soc Hematol Educ Program
, vol.2010
, pp. 144-149
-
-
Lee, A.Y.1
-
8
-
-
3042704507
-
Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: The fragmin advanced malignancy outcome study (FAMOUS)
-
DOI 10.1200/JCO.2004.10.002
-
Kakkar AK, Levine MN, Kadziola Z, Lemoine NR, Low V, Patel HK, Rustin G, Thomas M, Quigley M, Williamson RC. Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: the fragmin advanced malignancy outcome study (FAMOUS). J Clin Oncol 2004; 22:1944-8; PMID:15143088; http://dx.doi.org/10.1200/JCO.2004.10.002 (Pubitemid 41095187)
-
(2004)
Journal of Clinical Oncology
, vol.22
, Issue.10
, pp. 1944-1948
-
-
Kakkar, A.K.1
Levine, M.N.2
Kadziola, Z.3
Lemoine, N.R.4
Low, V.5
Patel, H.K.6
Rustin, G.7
Thomas, M.8
Quigley, M.9
Williamson, R.C.N.10
-
9
-
-
20244376337
-
The effect of low molecular weight heparin on survival in patients with advanced malignancy
-
DOI 10.1200/JCO.2005.03.134
-
Klerk CP, Smorenburg SM, Otten HM, Lensing AW, Prins MH, Piovella F, Prandoni P, Bos MM, Richel DJ, van Tienhoven G, et al. The effect of low molecular weight heparin on survival in patients with advanced malignancy. J Clin Oncol 2005; 23:2130-5; PMID:15699479; http://dx.doi.org/10.1200/JCO.2005. 03.134 (Pubitemid 46218704)
-
(2005)
Journal of Clinical Oncology
, vol.23
, Issue.10
, pp. 2130-2135
-
-
Klerk, C.P.W.1
Smorenburg, S.M.2
Otten, H.-M.3
Lensing, A.W.A.4
Prins, M.H.5
Piovella, F.6
Prandoni, P.7
Bos, M.M.E.M.8
Richel, D.J.9
Van Tienhoven, G.10
Buller, H.R.11
-
10
-
-
63649105562
-
Does antithrombotic therapy improve survival in cancer patients?
-
PMID:19046797
-
Cunningham MS, Preston RJ, O'Donnell JS. Does antithrombotic therapy improve survival in cancer patients? Blood Rev 2009; 23:129-35; PMID:19046797; http://dx.doi.org/10.1016/j. blre.2008.10.002
-
(2009)
Blood Rev
, vol.23
, pp. 129-135
-
-
Cunningham, M.S.1
Preston, R.J.2
O'Donnell, J.S.3
-
11
-
-
0034164514
-
Effect of low molecular weight heparin (Certoparin) versus unfractionated heparin on cancer survival following breast and pelvic cancer surgery: A prospective randomized double-blind trial
-
PMID:10717252
-
von Tempelhoff GF, Harenberg J, Niemann F, Hommel G, Kirkpatrick CJ, Heilmann L. Effect of low molecular weight heparin (Certoparin) versus unfractionated heparin on cancer survival following breast and pelvic cancer surgery: A prospective randomized double-blind trial. Int J Oncol 2000; 16:815-24; PMID:10717252
-
(2000)
Int J Oncol
, vol.16
, pp. 815-824
-
-
Von Tempelhoff, G.F.1
Harenberg, J.2
Niemann, F.3
Hommel, G.4
Kirkpatrick, C.J.5
Heilmann, L.6
-
12
-
-
84878661746
-
Perturbation of the heparin/heparin-sulfate interactome of human breast cancer cells modulates pro-tumourigenic effects associated with PI3K/Akt and MAPK/ERK signalling
-
PMID:23571852
-
Chen Y, Scully M, Dawson G, Goodwin C, Xia M, Lu X, Kakkar A. Perturbation of the heparin/heparin-sulfate interactome of human breast cancer cells modulates pro-tumourigenic effects associated with PI3K/Akt and MAPK/ERK signalling. Thromb Haemost 2013; 109:1148-57; PMID:23571852; http://dx.doi.org/10.1160/TH12-12-0935
-
(2013)
Thromb Haemost
, vol.109
, pp. 1148-1157
-
-
Chen, Y.1
Scully, M.2
Dawson, G.3
Goodwin, C.4
Xia, M.5
Lu, X.6
Kakkar, A.7
-
13
-
-
2542491777
-
The role of ABC transporters in drug resistance, metabolism and toxicity
-
PMID:16305368
-
Glavinas H, Krajcsi P, Cserepes J, Sarkadi B. The role of ABC transporters in drug resistance, metabolism and toxicity. Curr Drug Deliv 2004; 1:27-42; PMID:16305368; http://dx.doi.org/10.2174/1567201043480036
-
(2004)
Curr Drug Deliv
, vol.1
, pp. 27-42
-
-
Glavinas, H.1
Krajcsi, P.2
Cserepes, J.3
Sarkadi, B.4
-
14
-
-
0345688604
-
Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2)
-
DOI 10.1038/sj.onc.1206938, Drug Resistance
-
Doyle L, Ross DD. Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2). Oncogene 2003; 22:7340-58; PMID:14576842; http://dx.doi.org/10.1038/sj.onc.1206938 (Pubitemid 37487163)
-
(2003)
Oncogene
, vol.22
, Issue.47 REV. ISS. 6
, pp. 7340-7358
-
-
Doyle, L.A.1
Ross, D.D.2
-
15
-
-
77958025244
-
Structure and function of the human breast cancer resistance protein (BCRP/ABCG2)
-
PMID:20812902
-
Ni Z, Bikadi Z, Rosenberg MF, Mao Q. Structure and function of the human breast cancer resistance protein (BCRP/ABCG2). Curr Drug Metab 2010; 11:603-17; PMID:20812902; http://dx.doi.org/10.2174/138920010792927325
-
(2010)
Curr Drug Metab
, vol.11
, pp. 603-617
-
-
Ni, Z.1
Bikadi, Z.2
Rosenberg, M.F.3
Mao, Q.4
-
16
-
-
13644254794
-
Molecular mechanisms of drug resistance
-
DOI 10.1002/path.1706
-
Longley DB, Johnston PG. Molecular mechanisms of drug resistance. J Pathol 2005; 205:275-92; PMID:15641020; http://dx.doi.org/10.1002/path.1706 (Pubitemid 40227997)
-
(2005)
Journal of Pathology
, vol.205
, Issue.2
, pp. 275-292
-
-
Longley, D.B.1
Johnston, P.G.2
-
17
-
-
0034674901
-
A family of drug transporters: The multidrug resistance-associated proteins
-
Borst P, Evers R, Kool M, Wijnholds J. A family of drug transporters: the multidrug resistance-associated proteins. J Natl Cancer Inst 2000; 92:1295-302; PMID:10944550; http://dx.doi.org/10.1093/jnci/92.16.1295 (Pubitemid 30662093)
-
(2000)
Journal of the National Cancer Institute
, vol.92
, Issue.16
, pp. 1295-1302
-
-
Borst, P.1
Evers, R.2
Kool, M.3
Wijnholds, J.4
-
18
-
-
80053158526
-
Expression of P-gp, MRP, LRP, GST-p and TopoIIa and intrinsic resistance in human lung cancer cell lines
-
PMID:21805041
-
Wang J, Zhang J, Zhang L, Zhao L, Fan S, Yang Z, Gao F, Kong Y, Xiao GG, Wang Q. Expression of P-gp, MRP, LRP, GST-p and TopoIIa and intrinsic resistance in human lung cancer cell lines. Oncol Rep 2011; 26:1081-9; PMID:21805041
-
(2011)
Oncol Rep
, vol.26
, pp. 1081-1089
-
-
Wang, J.1
Zhang, J.2
Zhang, L.3
Zhao, L.4
Fan, S.5
Yang, Z.6
Gao, F.7
Kong, Y.8
Xiao, G.G.9
Wang, Q.10
-
19
-
-
0032817056
-
Adult T-cell leukemia cells over-express the multidrug-resistance- protein (MRP) and lung-resistance-protein (LRP) genes
-
DOI 10.1002/(SICI)1097-0215(19990812)82:4<599::AID-IJC21>3.0.CO;2-R
-
Ikeda K, Oka M, Yamada Y, Soda H, Fukuda M, Kinoshita A, Tsukamoto K, Noguchi Y, Isomoto H, Takeshima F, et al. Adult T-cell leukemia cells over-express the multidrug-resistance-protein (MRP) and lung-resistance-protein (LRP) genes. Int J Cancer 1999; 82:599-604; PMID:10404077; ht t p : //d x . d o i . o r g /10 .10 0 2 /( S ICI )10 9 7-0215(19990812)82:43.0.CO;2-R (Pubitemid 29343463)
-
(1999)
International Journal of Cancer
, vol.82
, Issue.4
, pp. 599-604
-
-
Ikeda, K.1
Oka, M.2
Yamada, Y.3
Soda, H.4
Fukuda, M.5
Kinoshita, A.6
Tsukamoto, K.7
Noguchi, Y.8
Isomoto, H.9
Takeshima, F.10
Murase, K.11
Kamihira, S.12
Tomonaga, M.13
Kohno, S.14
-
20
-
-
0030091652
-
Broad distribution of the multidrug resistance-related vault lung resistance protein in normal human tissues and tumors
-
Izquierdo MA, Scheffer GL, Flens MJ, Giaccone G, Broxterman HJ, Meijer CJ, van der Valk P, Scheper RJ. Broad distribution of the multidrug resistancerelated vault lung resistance protein in normal human tissues and tumors. Am J Pathol 1996; 148:877-87; PMID:8774142 (Pubitemid 126660679)
-
(1996)
American Journal of Pathology
, vol.148
, Issue.3
, pp. 877-887
-
-
Izquierdo, M.A.1
Scheffer, G.L.2
Flens, M.J.3
Giaccone, G.4
Broxterman, H.J.5
Meijer, C.J.L.M.6
Van Der Valk, P.7
Scheper, R.J.8
-
21
-
-
0029048485
-
The drug resistance-related protein LRP is the human major vault protein
-
PMID:7585126
-
Scheffer GL, Wijngaard PL, Flens MJ, Izquierdo MA, Slovak ML, Pinedo HM, Meijer CJ, Clevers HC, Scheper RJ. The drug resistance-related protein LRP is the human major vault protein. Nat Med 1995; 1:578-82; PMID:7585126; http://dx.doi.org/10.1038/nm0695-578
-
(1995)
Nat Med
, vol.1
, pp. 578-582
-
-
Scheffer, G.L.1
Wijngaard, P.L.2
Flens, M.J.3
Izquierdo, M.A.4
Slovak, M.L.5
Pinedo, H.M.6
Meijer, C.J.7
Clevers, H.C.8
Scheper, R.J.9
-
22
-
-
0023730691
-
Oestradiol enhances doxorubicin uptake and cytotoxicity in human breast cancer cells (MCF-7)
-
PMID:3181264
-
Bontenbal M, Sonneveld P, Foekens JA, Klijn JG. Oestradiol enhances doxorubicin uptake and cytotoxicity in human breast cancer cells (MCF-7). Eur J Cancer Clin Oncol 1988; 24:1409-14; PMID:3181264; http://dx.doi.org/10.1016/ 0277-5379(88)90329-X
-
(1988)
Eur J Cancer Clin Oncol
, vol.24
, pp. 1409-1414
-
-
Bontenbal, M.1
Sonneveld, P.2
Foekens, J.A.3
Klijn, J.G.4
-
23
-
-
61349188383
-
Annexin-1 regulates growth arrest induced by high levels of estrogen in MCF-7 breast cancer cells
-
PMID:19208747
-
Ang EZ, Nguyen HT, Sim HL, Putti TC, Lim LH. Annexin-1 regulates growth arrest induced by high levels of estrogen in MCF-7 breast cancer cells. Mol Cancer Res 2009; 7:266-74; PMID:19208747; http://dx.doi.org/10.1158/1541-7786. MCR-08-0147
-
(2009)
Mol Cancer Res
, vol.7
, pp. 266-274
-
-
Ang, E.Z.1
Nguyen, H.T.2
Sim, H.L.3
Putti, T.C.4
Lim, L.H.5
-
24
-
-
77955366419
-
LRP-1 promotes cancer cell invasion by supporting ERK and inhibiting JNK signaling pathways
-
PMID:20644732
-
Langlois B, Perrot G, Schneider C, Henriet P, Emonard H, Martiny L, Dedieu S. LRP-1 promotes cancer cell invasion by supporting ERK and inhibiting JNK signaling pathways. PLoS One 2010; 5:e11584; PMID:20644732; http://dx.doi.org/10.1371/journal.pone.0011584
-
(2010)
PLoS One
, vol.5
-
-
Langlois, B.1
Perrot, G.2
Schneider, C.3
Henriet, P.4
Emonard, H.5
Martiny, L.6
Dedieu, S.7
-
25
-
-
79960416727
-
Signal integration and coincidence detection in the mitogen-activated protein kinase/extracellular signal-regulated kinase (ERK) cascade: Concomitant activation of receptor tyrosine kinases and of LRP-1 leads to sustained ERK phosphorylation via down-regulation of dual specificity phosphatases (DUSP1 and-6)
-
PMID:21610072
-
Geetha N, Mihaly J, Stockenhuber A, Blasi F, Uhrin P, Binder BR, Freissmuth M, Breuss JM. Signal integration and coincidence detection in the mitogen-activated protein kinase/extracellular signal-regulated kinase (ERK) cascade: concomitant activation of receptor tyrosine kinases and of LRP-1 leads to sustained ERK phosphorylation via down-regulation of dual specificity phosphatases (DUSP1 and-6). J Biol Chem 2011; 286:25663-74; PMID:21610072; http://dx.doi.org/10.1074/jbc.M111.221903
-
(2011)
J Biol Chem
, vol.286
, pp. 25663-25674
-
-
Geetha, N.1
Mihaly, J.2
Stockenhuber, A.3
Blasi, F.4
Uhrin, P.5
Binder, B.R.6
Freissmuth, M.7
Breuss, J.M.8
-
26
-
-
33747288211
-
Cellular functions of vaults and their involvement in multidrug resistance
-
PMID:16918321
-
Steiner E, Holzmann K, Elbling L, Micksche M, Berger W. Cellular functions of vaults and their involvement in multidrug resistance. Curr Drug Targets 2006; 7:923-34; PMID:16918321; http://dx.doi.org/10.2174/ 138945006778019345
-
(2006)
Curr Drug Targets
, vol.7
, pp. 923-934
-
-
Steiner, E.1
Holzmann, K.2
Elbling, L.3
Micksche, M.4
Berger, W.5
-
27
-
-
33847660184
-
Modulatory effects of heparin on cellular accumulation and cytotoxicity of doxorubicin in MRP1-overexpressing HL60/doxo cells
-
PMID:17352253
-
Angelini A, Ciofani G, Baccante G, Di Febbo C, Carmine DI, Cuccurullo F, Porreca E. Modulatory effects of heparin on cellular accumulation and cytotoxicity of doxorubicin in MRP1-overexpressing HL60/doxo cells. Anticancer Res 2007; 27(1A):351-5; PMID:17352253
-
(2007)
Anticancer Res
, vol.27
, Issue.1 A
, pp. 351-355
-
-
Angelini, A.1
Ciofani, G.2
Baccante, G.3
Di Febbo, C.4
Carmine, D.I.5
Cuccurullo, F.6
Porreca, E.7
-
28
-
-
25144494127
-
Inhibition of P-glycoprotein-mediated multidrug resistance by unfractionated heparin. A new potential chemosensitizer for cancer therapy
-
Angelini A, Di Febbo C, Ciofani G, Di Nisio M, Baccante G, Di Ilio C, Cuccurullo F, Porreca E. Inhibition of P-glycoprotein-mediated multidrug resistance by unfractionated heparin: a new potential chemosensitizer for cancer therapy. Cancer Biol Ther 2005; 4:313-7; PMID:15876859; http://dx.doi.org/10. 4161/cbt.4.3.1503 (Pubitemid 41351292)
-
(2005)
Cancer Biology and Therapy
, vol.4
, Issue.3
, pp. 313-317
-
-
Angelini, A.1
Di Febbo, C.2
Ciofani, G.3
Di Nisio, M.4
Baccante, G.5
Di Ilio, C.6
Cuccurullo, F.7
Porreca, E.8
-
29
-
-
0347004626
-
Annexin-I expression modulates drug resistance in tumor cells
-
DOI 10.1016/j.bbrc.2003.12.117
-
Wang Y, Serfass L, Roy MO, Wong J, Bonneau AM, Georges E. Annexin-I expression modulates drug resistance in tumor cells. Biochem Biophys Res Commun 2004; 314:565-70; PMID:14733945; http://dx.doi.org/10.1016/j.bbrc.2003.12.117 (Pubitemid 38084756)
-
(2004)
Biochemical and Biophysical Research Communications
, vol.314
, Issue.2
, pp. 565-570
-
-
Wang, Y.1
Serfass, L.2
Roy, M.-O.3
Wong, J.4
Bonneau, A.-M.5
Georges, E.6
-
30
-
-
79957592466
-
A systems biology approach for the investigation of the heparin/heparan sulfate interactome
-
PMID:21454685
-
Ori A, Wilkinson MC, Fernig DG. A systems biology approach for the investigation of the heparin/heparan sulfate interactome. J Biol Chem 2011; 286:19892-904; PMID:21454685; http://dx.doi.org/10.1074/jbc.M111.228114
-
(2011)
J Biol Chem
, vol.286
, pp. 19892-19904
-
-
Ori, A.1
Wilkinson, M.C.2
Fernig, D.G.3
-
31
-
-
0032488840
-
Casein kinase II stabilizes the activity of human topoisomerase IIα in a phosphorylation-independent manner
-
DOI 10.1074/jbc.273.6.3635
-
Redwood C, Davies SL, Wells NJ, Fry AM, Hickson ID. Casein kinase II stabilizes the activity of human topoisomerase IIalpha in a phosphorylation- independent manner. J Biol Chem 1998; 273:3635-42; PMID:9452492; http://dx.doi.org/10.1074/jbc.273.6.3635 (Pubitemid 28109789)
-
(1998)
Journal of Biological Chemistry
, vol.273
, Issue.6
, pp. 3635-3642
-
-
Redwood, C.1
Davies, S.L.2
Wells, N.J.3
Fry, A.M.4
Hickson, I.D.5
-
32
-
-
0035933826
-
Pentosan polysulfate as an inhibitor of extracellular HIV-1 Tat
-
PMID:11304529
-
Rusnati M, Urbinati C, Caputo A, Possati L, Lortat-Jacob H, Giacca M, Ribatti D, Presta M. Pentosan polysulfate as an inhibitor of extracellular HIV-1 Tat. J Biol Chem 2001; 276:22420-5; PMID:11304529; http://dx.doi.org/10.1074/ jbc.M010779200
-
(2001)
J Biol Chem
, vol.276
, pp. 22420-22425
-
-
Rusnati, M.1
Urbinati, C.2
Caputo, A.3
Possati, L.4
Lortat-Jacob, H.5
Giacca, M.6
Ribatti, D.7
Presta, M.8
-
33
-
-
0037464302
-
Lung resistance-related protein as a predictor of clinical outcome in advanced testicular germ-cell tumours
-
DOI 10.1038/sj.bjc.6600803
-
Zurita AJ, Diestra JE, Condom E, García Del Muro X, Scheffer GL, Scheper RJ, Pérez J, Germà-Lluch JR, Izquierdo MA. Lung resistance-related protein as a predictor of clinical outcome in advanced testicular germ-cell tumours. Br J Cancer 2003; 88:879-86; PMID:12644825; http://dx.doi.org/10.1038/sj.bjc.6600803 (Pubitemid 36520875)
-
(2003)
British Journal of Cancer
, vol.88
, Issue.6
, pp. 879-886
-
-
Zurita, A.J.1
Diestra, J.E.2
Condom, E.3
Garcia Del Muro, X.4
Scheffer, G.L.5
Scheper, R.J.6
Perez, J.7
Germa-Lluch, J.R.8
Izquierdo, M.A.9
-
34
-
-
14044271561
-
Major vault protein does not play a role in chemoresistance or drug localization in a non-small cell lung cancer cell line
-
DOI 10.1021/bi047948g
-
Huffman KE, Corey DR. Major vault protein does not play a role in chemoresistance or drug localization in a non-small cell lung cancer cell line. Biochemistry 2005; 44:2253-61; PMID:15709737; http://dx.doi.org/10.1021/ bi047948g (Pubitemid 40279529)
-
(2005)
Biochemistry
, vol.44
, Issue.7
, pp. 2253-2261
-
-
Huffman, K.E.1
Corey, D.R.2
-
35
-
-
3142702834
-
Efflux kinetics and intracellular distribution of daunorubicin are not affected by major vault protein/lung resistance-related protein (vault) expression
-
DOI 10.1158/0008-5472.CAN-03-3891
-
van Zon A, Mossink MH, Schoester M, Scheper RJ, Sonneveld P, Wiemer EA. Efflux kinetics and intracellular distribution of daunorubicin are not affected by major vault protein/lung resistance-related protein (vault) expression. Cancer Res 2004; 64:4887-92; PMID:15256459; http://dx.doi.org/10.1158/0008-5472. CAN-03-3891 (Pubitemid 38924533)
-
(2004)
Cancer Research
, vol.64
, Issue.14
, pp. 4887-4892
-
-
Van Zon, A.1
Mossink, M.H.2
Schoester, M.3
Scheper, R.J.4
Sonneveld, P.5
Wiemer, E.A.C.6
-
36
-
-
34250711394
-
Depletion of major vault protein increases doxorubicin sensitivity and nuclear accumulation and disrupts its sequestration in lysosomes
-
DOI 10.1158/1535-7163.MCT-06-0372
-
Herlevsen M, Oxford G, Owens CR, Conaway M, Theodorescu D. Depletion of major vault protein increases doxorubicin sensitivity and nuclear accumulation and disrupts its sequestration in lysosomes. Mol Cancer Ther 2007; 6:1804-13; PMID:17575109; http://dx.doi.org/10.1158/1535-7163.MCT-06-0372 (Pubitemid 46954057)
-
(2007)
Molecular Cancer Therapeutics
, vol.6
, Issue.6
, pp. 1804-1813
-
-
Herlevsen, M.1
Oxford, G.2
Owens, C.R.3
Conaway, M.4
Theodorescu, D.5
-
37
-
-
84866548075
-
Overcoming drug resistance of MCF-7/ADR cells by altering intracellular distribution of doxorubicin via MVP knockdown with a novel siRNA polyamidoamine-hyaluronic acid complex
-
PMID:22940126
-
Han M, Lv Q, Tang XJ, Hu YL, Xu DH, Li FZ, Liang WQ, Gao JQ. Overcoming drug resistance of MCF-7/ADR cells by altering intracellular distribution of doxorubicin via MVP knockdown with a novel siRNA polyamidoamine-hyaluronic acid complex. J Control Release 2012; 163:136-44; PMID:22940126; http://dx.doi.org/ 10.1016/j.jconrel.2012.08.020
-
(2012)
J Control Release
, vol.163
, pp. 136-144
-
-
Han, M.1
Lv, Q.2
Tang, X.J.3
Hu, Y.L.4
Xu, D.H.5
Li, F.Z.6
Liang, W.Q.7
Gao, J.Q.8
-
38
-
-
0034687719
-
Rhodamine 123 binds to multiple sites in the multidrug resistance protein (MRP1)
-
DOI 10.1021/bi0020574
-
Daoud R, Kast C, Gros P, Georges E. Rhodamine 123 binds to multiple sites in the multidrug resistance protein (MRP1). Biochemistry 2000; 39:15344-52; PMID:11112520; http://dx.doi.org/10.1021/bi0020574 (Pubitemid 32002761)
-
(2000)
Biochemistry
, vol.39
, Issue.50
, pp. 15344-15352
-
-
Daoud, R.1
Kast, C.2
Gros, P.3
Georges, E.4
-
39
-
-
1242293677
-
Pheophorbide a Is a Specific Probe for ABCG2 Function and Inhibition
-
DOI 10.1158/0008-5472.CAN-03-3298
-
Robey RW, Steadman K, Polgar O, Morisaki K, Blayney M, Mistry P, Bates SE. Pheophorbide a is a specific probe for ABCG2 function and inhibition. Cancer Res 2004; 64:1242-6; PMID:14973080; http://dx.doi.org/10.1158/0008-5472.CAN-03- 3298 (Pubitemid 38235589)
-
(2004)
Cancer Research
, vol.64
, Issue.4
, pp. 1242-1246
-
-
Robey, R.W.1
Steadman, K.2
Polgar, O.3
Morisaki, K.4
Blayney, M.5
Mistry, P.6
Bates, S.E.7
-
40
-
-
84860498446
-
Interaction of phenothiazines, stilbenes and flavonoids with multidrug resistance-associated transporters, P-glycoprotein and MRP1
-
PMID:22187677
-
Wesolowska O. Interaction of phenothiazines, stilbenes and flavonoids with multidrug resistance-associated transporters, P-glycoprotein and MRP1. Acta Biochim Pol 2011; 58:433-48; PMID:22187677
-
(2011)
Acta Biochim Pol
, vol.58
, pp. 433-448
-
-
Wesolowska, O.1
-
41
-
-
52249116607
-
Imatinib-mediated inactivation of Akt regulates ABCG2 function in head and neck squamous cell carcinoma
-
PMID:18794444
-
Chu TS, Chen JS, Lopez JP, Pardo FS, Aguilera J, Ongkeko WM. Imatinib-mediated inactivation of Akt regulates ABCG2 function in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2008; 134:979-84; PMID:18794444; http://dx.doi.org/10.1001/archotol.134.9.979
-
(2008)
Arch Otolaryngol Head Neck Surg
, vol.134
, pp. 979-984
-
-
Chu, T.S.1
Chen, J.S.2
Lopez, J.P.3
Pardo, F.S.4
Aguilera, J.5
Ongkeko, W.M.6
-
42
-
-
71049156626
-
ABCG2: The key to chemoresistance in cancer stem cells?
-
PMID:19708828
-
An Y, Ongkeko WM. ABCG2: the key to chemoresistance in cancer stem cells? Expert Opin Drug Metab Toxicol 2009; 5:1529-42; PMID:19708828; http://dx.doi.org/10.1517/17425250903228834
-
(2009)
Expert Opin Drug Metab Toxicol
, vol.5
, pp. 1529-1542
-
-
An, Y.1
Ongkeko, W.M.2
-
43
-
-
28244436502
-
Matrix contraction by dermal fibroblasts requires transforming growth factor-β/activin-linked kinase 5, heparan sulfate-containing proteoglycans, and MEK/ERK: Insights into pathological scarring in chronic fibrotic disease
-
Chen Y, Shi-Wen X, van Beek J, Kennedy L, McLeod M, Renzoni EA, Bou-Gharios G, Wilcox-Adelman S, Goetinck PF, Eastwood M, et al. Matrix contraction by dermal fibroblasts requires transforming growth factor-beta/activin-linked kinase 5, heparan sulfatecontaining proteoglycans, and MEK/ERK: insights into pathological scarring in chronic fibrotic disease. Am J Pathol 2005; 167:1699-711; PMID:16314481; http://dx.doi.org/10.1016/S0002- 9440(10)61252-7 (Pubitemid 41713321)
-
(2005)
American Journal of Pathology
, vol.167
, Issue.6
, pp. 1699-1711
-
-
Chen, Y.1
Xu, S.-W.2
Van Beek, J.3
Kennedy, L.4
McLeod, M.5
Renzoni, E.A.6
Bou-Gharios, G.7
Wilcox-Adelman, S.8
Goetinck, P.F.9
Eastwood, M.10
Black, C.M.11
Abraham, D.J.12
Leask, A.13
|